The meeting will begin on Friday, March 23 with registration from 16:00 to 20:00 and a welcome mixer from 18:00 to 20:00. Conference events conclude on Tuesday, March 27 with a closing plenary session from 17:00 to 19:00, followed by a social hour and entertainment. We recommend return travel on Wednesday, March 28 in order to fully experience the meeting.

Speakers:

Karen Adelman, Harvard Medical School, USA

Geneviève Almouzni, Centre National de la Recherche Scientifique, France

Cheryl Arrowsmith, University of Toronto, Canada

Emily Bernstein, Mount Sinai School of Medicine, USA

Wendy A. Bickmore, University of Edinburgh, UK

James E. Bradner, Novartis Institutes for BioMedical Research, USA

Clifford P. Brangwynne, Princeton University, USA

Giacomo Cavalli, Institute of Human Genetics, France

Ibrahim Cissé, Massachusetts Institute of Technology, USA

Victor G. Corces, Emory University, USA

Patrick Cramer, Max Planck Institute for Biophysical Chemistry, Germany

Job Dekker, University of Massachusetts Medical School, USA

Jennifer A. Doudna, HHMI/University of California, Berkeley, USA

Denis Duboule, EPFL-SV-ISREC-UPDUB, Switzerland

Joseph R. Ecker, The Salk Institute for Biological Studies, USA

Ronald M. Evan, Howard Hughes Medical Institute, Salk Institute, USA

Peter Fraser, Florida State University, USA

Eileen E.M. Furlong, European Molecular Biology Laboratory, Germany

Susan M. Gasser, Friedrich Miescher Institute for Biomedical Research, Switzerland

William J. Greenleaf, Stanford University, USA

Mitchell Guttman, California Institute of Technology, USA

Suzana Hadjur, University College London, UK

Edith Heard, Institut Curie, France

Manolis Kellis, Massachusetts Institute of Technology / Broad Institute, USA

Wouter de Laat, Hubrecht Institute, Netherlands

Michael S. Levine, Princeton University, USA

Ross L. Levine, Memorial Sloan Kettering Cancer Center, USA

Stavros Lomvardas, Columbia University, USA

Marc A. Marti-Renom, CNAG-CRG, Spain

Leonid Mirny, Massachusetts Institute of Technology, USA

Stefan Mundlos, Max Planck Institute for Molecular Genetics, Germany

Geeta J. Narlikar, University of California, San Francisco, USA

William Stafford Noble, University of Washington, USA

Ana Pombo, Max-Delbrück-Centrum für Molekulare Medizin, Germany

Oliver J. Rando, University of Massachusetts Medical School, USA

Karen L. Reddy, Johns Hopkins University, USA

Bing Ren, Ludwig Institute for Cancer Research, USA

Peter C. Scacheri, Case Western Reserve University, USA

Phillip A. Sharp, Massachusetts Institute of Technology, USA

Jane A. Skok, New York University School of Medicine, USA

Mikhail Spivakov, Babraham Institute, UK

John A. Stamatoyannopoulos, University of Washington, USA

Bas van Steensel, Netherlands Cancer Institute, Netherlands

Amos Tanay, Weizmann Institute, Israel

Juanma Vaquerizas, Max Planck Institute for Molecular Biomedicine, Germany

Joanna Wysocka, Stanford University School of Medicine, USA

Richard A. Young, Whitehead Institute for Biomedical Research, USA

Magdalena Zernicka-Goetz, University of Cambridge, UK

Leonard I. Zon, HHMI/Boston Children’s Hospital, USA

 

Scholarship Deadline: Nov 28, 2017
Discounted Abstract Deadline: Nov 28, 2017
Abstract Deadline: Dec 20, 2017
Discounted Registration Deadline: Jan 17, 2018